Breakthroughs in Ophthalmic Devices and Drug Delivery Technologies (Technical Insights)

Venture Capital and Private Equity Firms Vital for Ophthalmic Device and Drug Delivery Innovation

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The aging of the population around the world will consequently lead to a rapid increase in the 65-and-over population by 2030, a population that accounts for the highest incidence and prevalence of eye conditions and diseases. This sets the stage for increased research and development activities, speedy market approvals, and higher awareness through education. The industry has been dominated by a few big players, however there are many small players/startups who have interesting ideas. This Research Service is focused on the shift in technologies and materials, regulatory platform, IP strength and funding scenario prevalent in the stent industry.

Table of Contents

Breakthroughs in Ophthalmic Devices and Drug Delivery Technologies (Technical Insights), Advances in Ophthalmic Devices and Drug Delivery Ophthalmic Devices and Drug DeliveryFunding Analysis




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.